Review

Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer

Mahtani RL, Vogel CL

Cancer Management and Research 2019, 11:513-524

Published Date: 4 January 2019